New BB0108, BB0126, BB0298, BB0323, and BB0689 Chromosomally Encoded Recombinant Proteins of Borrelia burgdorferi sensu lato for Serodiagnosis of Lyme Disease
Pathogens · 2024
DOI: 10.3390/pathogens13090767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Weronika Grąźlewska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Microbiology, Faculty of Chemistry, Gdańsk University of Technology, 80-233 Gdańsk, Poland. Hauptthemen laut MEDLINE: Lyme Disease, Recombinant Proteins, Serologic Tests, Antibodies, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Centre, Poland.
Abstract (Originalsprache)
Five chromosomally encoded proteins, BB0108, BB0126, BB0298, BB0323, and BB0689, from Borrelia burgdorferi sensu lato (s.l.), were obtained in three variants each, representing the most common genospecies found in Europe (Borrelia afzelii, Borrelia burgdorferi sensu stricto (s.s.), and Borrelia garinii). The reactivity of these recombinant proteins with the IgM and IgG antibodies present in human serum was assessed using Western blot (WB) and the ELISA. In IgG-WB, the proteins exhibited varying reactivity, peaking at approximately 40–50% for BB0108 and BB0689. However, none of these proteins were recognized by specific antibodies in the IgM-WB. The sensitivity of IgG-ELISA based on three variants of BB0108 and BB0323 ranged from 71% to 82% and from 62% to 72%, respectively. Conversely, the specificity of both tested proteins was consistently above 82%. Tests utilizing single variants of BB0323 did not yield any diagnostic value in detecting IgM antibodies. However, BB0108 demonstrated recognition by antibodies present in 52% to 63% of the tested sera. These antigens appear advantageous due to the consistent reactivity observed across their variants. This observation suggests that appropriate selection of antigens conserved within B. burgdorferi s.l. could offer a solution to the issue of variable sensitivity encountered in serodiagnostic tests across Europe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Microbiology, Faculty of Chemistry, Gdańsk University of Technology, 80-233 Gdańsk, Poland.
- Department of Parasitology and Diseases Transmitted by Vectors, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
ORCID-Profile: Tomasz Chmielewski, Lucyna Holec-Gąsior
Förderung
- National Science Center
- National Science Centre, Poland
Zitieren
APA
Grąźlewska, W., Chmielewski, T., Fiecek, B., & Holec-Gąsior, L. (2024). New BB0108, BB0126, BB0298, BB0323, and BB0689 Chromosomally Encoded Recombinant Proteins of Borrelia burgdorferi sensu lato for Serodiagnosis of Lyme Disease. Pathogens. https://doi.org/10.3390/pathogens13090767
Vancouver
Grąźlewska W, Chmielewski T, Fiecek B, Holec-Gąsior L. New BB0108, BB0126, BB0298, BB0323, and BB0689 Chromosomally Encoded Recombinant Proteins of Borrelia burgdorferi sensu lato for Serodiagnosis of Lyme Disease. Pathogens. 2024. doi:10.3390/pathogens13090767
BibTeX
@article{Grlewska2024,
author = {Grąźlewska, Weronika and Chmielewski, Tomasz and Fiecek, Beata and Holec-Gąsior, Lucyna},
title = {New BB0108, BB0126, BB0298, BB0323, and BB0689 Chromosomally Encoded Recombinant Proteins of Borrelia burgdorferi sensu lato for Serodiagnosis of Lyme Disease},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13090767}
}
EUVIMED